0001144204-17-012692.txt : 20170303 0001144204-17-012692.hdr.sgml : 20170303 20170303141805 ACCESSION NUMBER: 0001144204-17-012692 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170303 DATE AS OF CHANGE: 20170303 EFFECTIVENESS DATE: 20170303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Envisagenics, Inc. CENTRAL INDEX KEY: 0001699688 IRS NUMBER: 465496412 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-281766 FILM NUMBER: 17662851 BUSINESS ADDRESS: STREET 1: 335 MADISON AVE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017-4616 BUSINESS PHONE: (516) 847-5485 MAIL ADDRESS: STREET 1: 335 MADISON AVE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017-4616 D 1 primary_doc.xml X0707 D LIVE 0001699688 Envisagenics, Inc. 335 MADISON AVE 3RD FLOOR NEW YORK NY NEW YORK 10017-4616 (516) 847-5485 DELAWARE None None Corporation true 2014 Maria Luisa Pineda 335 Madison Ave 3rd Floor New York NY NEW YORK 10017-4616 Executive Officer Director Promoter Martin Akerman 335 Madison Ave 3rd Floor New York NY NEW YORK 10017-4616 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false true false true Convertible Promissory Notes convertible into Equity Securities false 0 2000000 0 2000000 false 0 0 0 0 false Envisagenics, Inc. /s/ Maria Luisa Pineda Maria Luisa Pineda Co-President 2017-02-27